Progress in Neurology and Psychiatry
Scope & Guideline
Enhancing care through cutting-edge research and discourse.
Introduction
Aims and Scopes
- Neuropsychiatric Disorders:
The journal emphasizes research on disorders that exhibit both neurological and psychiatric symptoms, such as dementia, epilepsy, and multiple sclerosis. It aims to explore the underlying mechanisms, treatment strategies, and patient outcomes associated with these conditions. - Innovative Treatment Approaches:
A significant focus is placed on novel therapeutic strategies, including pharmacological interventions, non-pharmacological treatments, and emerging technologies, to improve care in neurology and psychiatry. - Interdisciplinary Collaboration:
The journal promotes collaboration between various healthcare professionals, including neurologists, psychiatrists, psychologists, and social workers, to foster comprehensive care models for patients with complex needs. - Clinical Guidelines and Evidence-Based Practice:
The publication seeks to provide clinicians with evidence-based guidelines and recommendations, facilitating informed decision-making in the management of neurological and psychiatric disorders. - Research on Psychotropic Medications:
A core area of interest involves the evaluation of psychotropic medications, addressing issues such as efficacy, side effects, and the impact of various drug regimens on patient health.
Trending and Emerging
- Impact of COVID-19 on Mental Health:
A growing body of research is focused on the psychological and neurological impacts of the COVID-19 pandemic, including increased rates of anxiety, depression, and cognitive decline among patients, especially those with pre-existing conditions. - Integration of Technology in Treatment:
Emerging themes include the use of digital health tools, apps, and wearable technology to enhance patient management and treatment adherence, showcasing the journal's commitment to innovative care solutions. - Trauma-Informed Care:
There is an increasing emphasis on trauma-informed approaches in managing various mental health conditions, particularly in populations with complex needs such as those with intellectual disabilities or dementia. - Pharmacogenetics and Personalized Medicine:
Research on pharmacogenetic analysis to tailor psychiatric treatments is trending, highlighting the importance of personalized medicine in optimizing therapeutic outcomes. - Multidisciplinary Approaches to Complex Cases:
The journal is seeing a rise in studies advocating for multidisciplinary team management of patients with complex neuropsychiatric disorders, emphasizing collaborative care strategies.
Declining or Waning
- Traditional Neurological Disorders:
Research focused solely on traditional neurological disorders, such as stroke or Parkinson’s disease, appears to be dwindling, possibly overshadowed by the growing interest in the neuropsychiatric interface and the impact of mental health on neurological conditions. - Generalized Psychiatry Topics:
Topics that cover broad psychiatric issues without a specific neurological component, such as general depression or anxiety without comorbid conditions, are less frequently addressed, indicating a shift towards more integrated studies. - Historical Perspectives:
Papers exploring historical perspectives or long-term trends in psychiatric or neurological treatment are becoming less common, as the journal emphasizes contemporary issues and innovative treatment methods. - Pharmacology of Older Medications:
There is a noticeable decrease in studies focusing on older psychotropic medications, such as traditional antipsychotics, as newer agents and treatment strategies gain more attention.
Similar Journals
JOURNAL OF CLINICAL PSYCHIATRY
Transforming clinical psychiatry with evidence-based insights.The JOURNAL OF CLINICAL PSYCHIATRY is a premier publication dedicated to advancing the understanding and treatment of psychiatric disorders. Established in 1978 and published by Physicians Postgraduate Press, this esteemed journal provides a vital platform for researchers, clinicians, and mental health professionals to share innovative findings and evidence-based practices in psychiatry. With an impressive impact factor and recognized as a Q1 journal in both Medicine (miscellaneous) and Psychiatry and Mental Health, the journal ranks among the top in its field, sitting at 96th out of 567 in Scopus rankings, placing it in the 83rd percentile. The journal's commitment to high-quality, peer-reviewed articles facilitates the dissemination of knowledge crucial for advancing clinical practices and improving patient outcomes. Access to its latest research is offered through institutional subscriptions, making it an essential resource for anyone involved in the mental health sector, from seasoned practitioners to aspiring students.
NEUROLOGIST
Cultivating Excellence in Neurology and MedicineNEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.
Dusunen Adam-Journal of Psychiatry and Neurological Sciences
Innovating Research for a Healthier Mind and BrainDusunen Adam-Journal of Psychiatry and Neurological Sciences is a vital resource for scholars and practitioners in the fields of psychiatry and neurology, published by KARE PUBL in Turkey. With an ISSN of 1018-8681 and E-ISSN 1309-5749, this journal has steadily contributed to the academic discourse since its inception, with a dedicated focus on contemporary issues and research findings in psychological and neurological sciences. The journal, which is recognized as Q3 in both the Neurology (clinical) and Psychiatry and Mental Health categories, currently ranks #413 out of 567 in Psychiatry and Mental Health and #298 out of 400 in clinical Neurology according to Scopus. Its commitment to advancing knowledge in these critical areas makes it a significant platform for researchers, professionals, and students alike, fostering a deeper understanding of mental health and neurological disorders that are increasingly relevant in our society. As Dusunen Adam continues to evolve through its convergence years from 2011 to 2024, it remains dedicated to enhancing the quality of life through research and evidence-based practices.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
Fostering Dialogue on Neurological and Psychiatric InnovationsFORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE is a pivotal journal in the fields of neurology, psychiatry, and related medical disciplines, published by GEORG THIEME VERLAG KG in Germany. With a history dating back to 1955, this journal has evolved to address the dynamic nature of neurological and psychiatric research, offering valuable insights and advancements in the field. Despite holding a Q4 category status in various medical domains according to the 2023 quartiles, the journal continues to foster academic discussion and engagement among researchers and clinicians alike. It serves as a vital platform for disseminating knowledge through original research articles, reviews, and clinical studies, making it an essential resource for professionals and students aiming to stay abreast of the latest developments in mental health and neurological science. Although the journal currently does not offer open access options, its contribution to the academic community is significant, helping to illuminate the intricate relationships between neurological disorders and psychiatric conditions.
Seminars in Pediatric Neurology
Transforming care through cutting-edge discoveries.Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.
Therapeutic Advances in Neurological Disorders
Championing open access to neurological advancements worldwide.Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.
BJPsych Open
Advancing mental health scholarship for a brighter tomorrow.BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.
BRITISH JOURNAL OF PSYCHIATRY
Leading the Dialogue in Psychiatry and Mental HealthBritish Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.
Future Neurology
Fostering collaboration in the evolving world of neurology.Future Neurology, published by Future Medicine Ltd, is an emerging peer-reviewed journal dedicated to the rapidly evolving field of neurology, with a keen focus on both clinical and translational research. Since its inception in 2007, the journal has provided a unique platform for sharing innovative findings and fostering collaboration among neurologists, neuroscientists, and healthcare professionals. Although currently categorized in the Q4 quartile for both Neurology and Clinical Neurology, Future Neurology strives to improve its impact factor by publishing high-quality research and reviews that address pressing issues in neurological health. With its commitment to disseminating knowledge, the journal serves as an essential resource for professionals and researchers seeking to stay informed about advancements in neurological science. It is particularly valuable for those looking to contribute to and engage with the latest developments in neurotherapeutics, diagnostics, and patient care strategies. The journal is indexed in major databases and is available in print and online formats, ensuring wider accessibility to its content for all stakeholders in the field.
Rivista di Psichiatria
Elevating Conversations in Mental Health ResearchRivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.